Ovarian Neoplasms: all 2,759 studies
Page 15 of 28. Open to participants first (736), then studies with results posted, then the rest; newest registration first within each.
- Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy TreatmentStatus unknownNCT05274867
- A Study to Investigate LYL797 in Adults With Solid TumorsTerminatedNCT05274451Phase 1
- Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese PatientsStatus unknownNCT05273944Phase 1
- Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian CancerStatus unknownNCT05270720Phase 1
- The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort StudyStatus unknownNCT05265117
- KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian CancerCompletedNCT05256576Not applicable
- An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted TherapyStatus unknownNCT05255861
- (VELA) Study of BLU-222 in Advanced Solid TumorsTerminatedNCT05252416Phase 1
- NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTerminatedNCT05252390Phase 1
- The Effect of Logotherapy on Mental Health in Gynecological Cancer PatientsCompletedNCT05246462Not applicable
- Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial)Status unknownNCT05246020Phase 2
- Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only PillsStatus unknownNCT05244811Phase 3
- Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT05243524Phase 2
- P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsActive, not recruitingNCT05239143Phase 1
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- A Study of SGN-ALPV in Advanced Solid TumorsTerminatedNCT05229900Phase 1
- A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian CancerTerminatedNCT05226507Phase 1
- Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
- Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological CancerActive, not recruitingNCT05220033Not applicable
- [18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian CancerTerminatedNCT05215496Phase 1
- Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual DiseaseActive, not recruitingNCT05212779
- Evaluation of Prognostic Factors for Tubo-ovarian Cancer in FranceCompletedNCT05204342
- APX005M in Patients With Recurrent Ovarian CancerWithdrawnNCT05201001Phase 2
- A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian CancerTerminatedNCT05200364Phase 1
- A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian CancerCompletedNCT05198804Phase 1/2
- A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
- Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian CancerCompletedNCT05188781
- Mapping Sentinel Lymph Node in Initial Stages of Ovarian CancerStatus unknownNCT05184140Not applicable
- Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyStatus unknownNCT05180851Early Phase 1
- GEN1047 for Solid Tumors - First in Human (FIH) TrialTerminatedNCT05180474Phase 1/2
- Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor DrugsStatus unknownNCT05175326
- A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian CancerStatus unknownNCT05170594Phase 2
- Artificial inTelligence in eNdometriosis-related ovArian Cancer and Precision Surgery in eNdometriosis-related ovArian CancerStatus unknownNCT05161949
- Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian CancerStatus unknownNCT05158062Phase 2
- Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian CancerActive, not recruitingNCT05156892Phase 1
- Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical SettingStatus unknownNCT05153603
- miRNAs in High Grade Serous Ovarian CancerStatus unknownNCT05146505
- Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian CancerWithdrawnNCT05145569Phase 2
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian CancerStatus unknownNCT05145218Phase 3
- A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
- Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.CompletedNCT05130515Phase 2
- Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPiWithdrawnNCT05126342Phase 2
- HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsTerminatedNCT05124743
- Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian CancerCompletedNCT05092763Not applicable
- The Effect of Glucose Level and Diabetes Mellitus on Ctrough of OlaparibStatus unknownNCT05081765
- Using Aspirin to Improve Immunological Features of Ovarian TumorsSuspendedNCT05080946Early Phase 1
- Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsActive, not recruitingNCT05075993Phase 1
- Variance of HRD From Paired Ovarian CancerStatus unknownNCT05069818
- Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian CancerStatus unknownNCT05059782Not applicable
- Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingActive, not recruitingNCT05059522Phase 3
- A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
- Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerActive, not recruitingNCT05053230Not applicable
- Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsCompletedNCT05047926Not applicable
- Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian CancerCompletedNCT05044871Phase 2
- Homologous Recombination Deficiency in Chinese Ovarian Cancer PatientsStatus unknownNCT05044091
- A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell CarcinomaActive, not recruitingNCT05043922Phase 2
- A Study of Navicixizumab in Patients With Platinum Resistant Ovarian CancerStatus unknownNCT05043402Phase 3
- A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesActive, not recruitingNCT05032040Phase 2
- Exercise Preconditioning in Ovarian CancerTerminatedNCT05029154Not applicable
- Ask Questions (ASQ):Implementation of a Communication InterventionCompletedNCT05025748Not applicable
- A Study of Niraparib in Patients With Ovarian Cancer in Clinical PracticeCompletedNCT05021562
- Thiol-disulfide Homeostasis in Patients With Ovarian CancerCompletedNCT05011539
- Survival Impact of Internal Mammary or Supraclavicular LymphadenectomyCompletedNCT05005650
- A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)TerminatedNCT05001282Phase 1/2
- A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian CancerTerminatedNCT04999605Phase 1/2
- A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )Status unknownNCT04998760Phase 2
- Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian CancerStatus unknownNCT04986371
- Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOCStatus unknownNCT04983550Phase 2
- Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian CancerStatus unknownNCT04971421
- Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus BiosimilarsCompletedNCT04971304
- A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursActive, not recruitingNCT04969835Phase 1
- Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Active, not recruitingNCT04956640Phase 1/2
- Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study)CompletedNCT04945187Not applicable
- OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian CancerWithdrawnNCT04941378Phase 1
- Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerActive, not recruitingNCT04938583Phase 1/2
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian TumorsActive, not recruitingNCT04931342Phase 2
- Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP InhibitorsCompletedNCT04917744
- Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian CancerStatus unknownNCT04911114Not applicable
- A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian CancerCompletedNCT04908787Phase 3
- Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian CancerTerminatedNCT04907968Phase 1
- Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer SurgeryCompletedNCT04906187Not applicable
- Feasibility Study of a 4 Stage Bowel Obstruction Cancer DietCompletedNCT04898842Not applicable
- A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) ParticipantsTerminatedNCT04893551Phase 1
- Study of ESG401 in Adults With Solid TumorsCompletedNCT04892342Phase 1/2
- Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian CancerTerminatedNCT04891185Phase 2
- A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawnNCT04889495
- Reprab Study: PLD + Trabectedin RechallengeStatus unknownNCT04887961Phase 2
- Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian CancerStatus unknownNCT04885270Phase 3
- D9319C00001- 1L OC Mono Global RCTActive, not recruitingNCT04884360Phase 3
- Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.CompletedNCT04881045Phase 1
- A Study of Intra-operative Imaging in Women With Ovarian CancerActive, not recruitingNCT04878094Phase 3
- Study of AK112 in the Treatment of Advanced Gynecological TumorsCompletedNCT04870177Phase 2
- Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian CancerStatus unknownNCT04864431Not applicable
- NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients.TerminatedNCT04861181Phase 4
- Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic ProceduresTerminatedNCT04849858Phase 3
- Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid TumorsSuspendedNCT04840589Phase 1
- Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian CancerActive, not recruitingNCT04830709
- Study of DP303c Injection in Patients With Advanced Ovarian CancerStatus unknownNCT04828616Phase 2